長雙歧桿菌
外觀
長雙歧桿菌 | |
---|---|
長雙歧桿菌的菌落 | |
科學分類 | |
域: | 細菌域 Bacteria |
門: | 放線菌門 Actinomycetota |
綱: | 放線菌綱 Actinomycetes |
目: | 雙歧桿菌目 Bifidobacteriales |
科: | 雙歧桿菌科 Bifidobacteriaceae |
屬: | 雙歧桿菌屬 Bifidobacterium |
種: | 長雙歧桿菌 B. longum
|
二名法 | |
Bifidobacterium longum |
長雙歧桿菌(學名:Bifidobaterium longum)又稱龍根菌,是雙歧桿菌屬的一種厭氧細菌[2][3],屬革蘭氏陽性菌。此菌可生長在人類消化道中並產生乳酸[4],是嬰兒腸道中最早出現的菌種之一[2]。長雙歧桿菌絕大多數情況不會致病,常被添加至食品中作為發酵用途[2][5]。
分類
[編輯]2002年,16S 核糖體RNA序列分析的結果顯示長雙歧桿菌與同屬另兩種細菌嬰兒雙歧桿菌(B. infantis)和豬雙歧桿菌(B. Suis)的序列相似度高達97%,應屬同一物種[6][7]。
生長環境
[編輯]嬰兒腸道中有高達九成的細菌為包括本種在內的雙歧桿菌屬細菌[3],其比例會隨嬰兒長大成人而逐漸減少,成人的腸道中僅有3%的細菌為雙歧桿菌,多種擬桿菌屬與真桿菌屬的細菌取代該屬細菌而成為優勢物種[4]。有些長雙歧桿菌的菌株對胃酸和膽汁抗性很高,因此能在胃中存活,並進入腸道中[5][8]。
長雙歧桿菌具有線毛,可與腸上皮細胞表面的醣蛋白結合,另外其細胞壁上的脂壁酸與帶有電荷的多醣也能幫助此菌結合腸上皮細胞[2][9]。
研究
[編輯]免疫系統調節
[編輯]使用長雙歧桿菌已被證明可以縮短與普通感冒相關的症狀的持續時間並最大程度地減輕其嚴重程度,其效果與神經氨酸酶抑製劑治療流感的效果相似。
長雙歧桿菌 BB536
[編輯]長雙歧桿菌BB536於1969年在健康母乳餵養嬰兒的腸道中發現[10]。它經常用於營養補充劑。在一些小型臨床試驗中,它已被證明可以幫助排便並緩解乳糖不耐症狀。[11][12]
參考文獻
[編輯]- ^ Parte, A.C. Bifidobacterium. LPSN. [2024-03-22]. (原始內容存檔於2021-01-25).
- ^ 2.0 2.1 2.2 2.3 Schell, M. A.; Karmirantzou, M.; Snel, B.; Vilanova, D.; Berger, B.; Pessi, G.; Zwahlen, M. -C.; Desiere, F.; Bork, P.; Delley, M.; Pridmore, R. D.; Arigoni, F. The genome sequence of Bifidobacterium longum reflects its adaptation to the human gastrointestinal tract. Proceedings of the National Academy of Sciences. 2002, 99 (22): 14422–14427. Bibcode:2002PNAS...9914422S. PMC 137899 . PMID 12381787. doi:10.1073/pnas.212527599 .
- ^ 3.0 3.1 Garrido, D.; Ruiz-Moyano, S.; Jimenez-Espinoza, R.; Eom, H. J.; Block, D. E.; Mills, D. A. Utilization of galactooligosaccharides by Bifidobacterium longum subsp. Infantis isolates. Food Microbiology. 2013, 33 (2): 262–270. PMC 3593662 . PMID 23200660. doi:10.1016/j.fm.2012.10.003.
- ^ 4.0 4.1 Yuan, Jing; Zhu, Li; Liu, Xiankai; Li, Ting; Zhang, Ying; Ying, Tianyi; Wang, Bin; Wang, Junjun; Dong, Hua; Feng, Erling; Li, Qiang; Wang, Jie; Wang, Hongxia; Wei, Kaihua; Zhang, Xuemin; Huang, Cuifeng; Huang, Peitang; Huang, Liuyu; Zeng, Ming; Wang, Hengliang. A Proteome Reference Map and Proteomic Analysis of Bifidobacterium longum NCC2705. Molecular & Cellular Proteomics. June 2006, 5 (6): 1105–1118. PMID 16549425. doi:10.1074/mcp.M500410-MCP200 .
- ^ 5.0 5.1 Yazawa, Kazuyuki; Fujimori, Minoru; Amano, Jun; Kano, Yasunobu; Taniguchi, Shun'ichiro. Bifidobacterium longum as a delivery system for cancer gene therapy: Selective localization and growth in hypoxic tumors. Cancer Gene Therapy. February 2000, 7 (2): 269–274. PMID 10770636. S2CID 7375660. doi:10.1038/sj.cgt.7700122.
- ^ Sakata, Shinji; Kitahara, Maki; Sakamoto, Mitsuo; Hayashi, Hidenori; Fukuyama, Masafumi; Benno, Yoshimi. Unification of Bifidobacterium infantis and Bifidobacterium suis as Bifidobacterium longum. International Journal of Systematic and Evolutionary Microbiology. 1 November 2002, 52 (6): 1945–1951. PMID 12508852. doi:10.1099/00207713-52-6-1945.
- ^ Mattarelli, P.; Bonaparte, C.; Pot, B.; Biavati, B. Proposal to reclassify the three biotypes of Bifidobacterium longum as three subspecies: Bifidobacterium longum subsp. longum subsp. nov., Bifidobacterium longum subsp. infantis comb. nov. and Bifidobacterium longum subsp. suis comb. nov.. International Journal of Systematic and Evolutionary Microbiology. 1 April 2008, 58 (4): 767–772. PMID 18398167. doi:10.1099/ijs.0.65319-0 .
- ^ Xiao, J.Z.; Kondo, S.; Takahashi, N.; Miyaji, K.; Oshida, K.; Hiramatsu, A.; Iwatsuki, K.; Kokubo, S.; Hosono, A. Effects of Milk Products Fermented by Bifidobacterium longum on Blood Lipids in Rats and Healthy Adult Male Volunteers. Journal of Dairy Science. July 2003, 86 (7): 2452–2461. PMID 12906063. doi:10.3168/jds.S0022-0302(03)73839-9 .
- ^ Abbad Andaloussi, S.; Talbaoui, H.; Marczak, R.; Bonaly, R. Isolation and characterization of exocellular polysaccharides produced by Bifidobacterium longum. Applied Microbiology and Biotechnology. November 1995, 43 (6): 995–1000. PMID 8590666. S2CID 10837355. doi:10.1007/BF00166915.
- ^ Minami, Miki; Tsuji, Shoji; Akagawa, Shohei; Akagawa, Yuko; Yoshimoto, Yuki; Kawakami, Hirosato; Kohno, Mamiko; Kaneko, Kazunari. Effect of a Bifidobacterium-Containing Acid-Resistant Microcapsule Formulation on Gut Microbiota: A Pilot Study. Nutrients. 2022-11-15, 14 (22) [2024-04-12]. ISSN 2072-6643. doi:10.3390/nu14224829. (原始內容存檔於2024-03-27) (英語).
- ^ Takeda, Tsutomu; Asaoka, Daisuke; Nojiri, Shuko; Yanagisawa, Naotake; Nishizaki, Yuji; Osada, Taro; Koido, Shigeo; Nagahara, Akihito; Katsumata, Noriko; Odamaki, Toshitaka; Xiao, Jin-Zhong. Usefulness of Bifidobacterium longum BB536 in Elderly Individuals With Chronic Constipation: A Randomized Controlled Trial. American Journal of Gastroenterology. 2023-03, 118 (3). ISSN 0002-9270. PMC 9973440 . PMID 36216361. doi:10.14309/ajg.0000000000002028 (英語).
- ^ Vitellio, Paola; Celano, Giuseppe; Bonfrate, Leonilde; Gobbetti, Marco; Portincasa, Piero; De Angelis, Maria. Effects of Bifidobacterium longum and Lactobacillus rhamnosus on Gut Microbiota in Patients with Lactose Intolerance and Persisting Functional Gastrointestinal Symptoms: A Randomised, Double-Blind, Cross-Over Study. Nutrients. 2019-04-19, 11 (4) [2024-04-12]. ISSN 2072-6643. PMC 6520754 . PMID 31010241. doi:10.3390/nu11040886. (原始內容存檔於2024-04-13) (英語).